ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,040.53
-0.50%
US Tech 100
20,778.00
-0.69%
다우존스 지수
44,544.66
-0.75%
Bitcoin
102,251.93
-0.16%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC

  6. Quadient SA (PK) (NPACF) 시세

Quadient SA (PK)

Quadient SA (PK) (NPACF)

USOTC
18.70
0.00
(0.00%)
마감 02 2월 6:00AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
18.70
매수가
17.04
매도가
20.66
거래량
-
0.00 일간 변동폭 0.00
18.70 52주 범위 23.65
market_cap
643.109M
전일 종가
18.70
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
34,390,834
배당수익률
3.35%
주가수익률
9.13
주당순이익(EPS)
2
매출
1.07B
순이익
68.7M

Quadient SA (PK) 정보

섹터
Equip Rental & Leasing, Nec
산업
Equip Rental & Leasing, Nec
웹사이트
www.quadient.com
본부
Bagneux, Hauts-de-seine, Fra
설립됨
-
Quadient SA (PK) is listed in the Equip Rental & Leasing sector of the OTC 시장 with ticker NPACF. The last closing price for Quadient (PK) was US$18.70. Over the last year, Quadient (PK) shares have traded in a share price range of US$ 18.70 to US$ 23.65.

Quadient (PK) currently has 34,390,834 shares in issue. The market capitalisation of Quadient (PK) is US$643.11 million. Quadient (PK) has a price to earnings ratio (PE ratio) of 9.13.

NPACF 최신 뉴스

추가 뉴스
No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
26-2.15-10.311750599520.8520.8518.713318.7CS
52-2.3-10.95238095242123.6518.721321.74411765CS
156-1.18-5.9356136820919.8823.6513.1932119.9603004CS
260-4.6-19.742489270423.332.1113.1938322.31674338CS

NPACF - Frequently Asked Questions (FAQ)

What is the current Quadient (PK) share price?
The current share price of Quadient (PK) is US$ 18.70
How many Quadient (PK) shares are in issue?
Quadient (PK) has 34,390,834 shares in issue
What is the market cap of Quadient (PK)?
The market capitalisation of Quadient (PK) is USD 643.11M
What is the 1 year trading range for Quadient (PK) share price?
Quadient (PK) has traded in the range of US$ 18.70 to US$ 23.65 during the past year
What is the PE ratio of Quadient (PK)?
The price to earnings ratio of Quadient (PK) is 9.13
What is the cash to sales ratio of Quadient (PK)?
The cash to sales ratio of Quadient (PK) is 0.59
What is the reporting currency for Quadient (PK)?
Quadient (PK) reports financial results in EUR
What is the latest annual turnover for Quadient (PK)?
The latest annual turnover of Quadient (PK) is EUR 1.07B
What is the latest annual profit for Quadient (PK)?
The latest annual profit of Quadient (PK) is EUR 68.7M
What is the registered address of Quadient (PK)?
The registered address for Quadient (PK) is 42-46, AVENUE ARISTIDE BRIAND, BAGNEUX, HAUTS-DE-SEINE, 92220
What is the Quadient (PK) website address?
The website address for Quadient (PK) is www.quadient.com
Which industry sector does Quadient (PK) operate in?
Quadient (PK) operates in the EQUIP RENTAL & LEASING, NEC sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NXGBNxGen Brands Inc (CE)
US$ 0.003
(299,900.00%)
180.55k
DOCKFBeyond Med Technologies Inc (PK)
US$ 0.055
(54,900.00%)
3.05k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0004
(39,900.00%)
52.05k
LTFDLittlefield Corporation (CE)
US$ 0.1525
(38,025.00%)
240
SGMDSugarmade Inc (CE)
US$ 0.0003
(29,900.00%)
5.94k
RTNBroot9B Holdings Inc (CE)
US$ 0.000001
(-99.97%)
666
THMOThermoGenesis Holdings Inc (CE)
US$ 0.000001
(-99.86%)
250
DOMWFPrime Drink Group Corporation (PK)
US$ 0.0012
(-99.08%)
311.03k
TTCMTautachrome Inc (CE)
US$ 0.000001
(-99.00%)
125.07k
MITJFMint Corporation (CE)
US$ 0.0001
(-99.00%)
12k
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
316.07M
HMBLHUMBL Inc (PK)
US$ 0.0007
(0.00%)
218.85M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(-25.00%)
210.68M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(0.00%)
171.31M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00275
(-1.79%)
134.31M

토론

전체 피드 보기
Kam8 Kam8 3 시간 전
LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
NWBO
manibiotech manibiotech 3 시간 전
Agree
Usual few will pump this anyway 
NWBO
manibiotech manibiotech 3 시간 전
lol 
The ceiling has already been put at 40M shares
So dream on
NWBO
Deportes Deportes 3 시간 전
Gfy is that better?
ENZC
Hicham007 Hicham007 3 시간 전
Painful but nothing new...

I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

I am ready finan
IOVA
jammy32 jammy32 3 시간 전
As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
API
rosemountbomber rosemountbomber 3 시간 전
Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
API
BlazingStocks BlazingStocks 3 시간 전
$ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
ILLR
barnstormer barnstormer 3 시간 전
OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
40,000,000 shares / 700,104 = 57.14 years
NWBO
BlazingStocks BlazingStocks 3 시간 전
Thank you for sharing this! 
ILLR
VMLG17 VMLG17 3 시간 전
And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
NWBO
Macod Macod 3 시간 전
CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

O/S 526,142,269
Restricted 297,633,160
Unrestricted 228,509,109

Increase of 7,6
MRGE
mascale mascale 3 시간 전
Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
HIRU
stealofadeal stealofadeal 3 시간 전
$ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
BLTHD
nowwhat2 nowwhat2 3 시간 전
scoop um up right at black swan.
XRPUSD
loophole lawyer loophole lawyer 3 시간 전
The 3 most important letters for GTCH…..P,C,T……Checkmate
GTCH
Preciouslife1 Preciouslife1 3 시간 전
https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
jxyzobrien jxyzobrien 3 시간 전
hope you are well
sounds like your company is doing great
say hi when you can
flipper44 flipper44 3 시간 전
The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
NWBO
x993231 x993231 3 시간 전
He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
LWLG
havnagoodtime havnagoodtime 3 시간 전
So, what is the short interest and the FTD report on DPLS? Thanks in advance.
DPLS
MartinLutherKing MartinLutherKing 3 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
gladeshawk gladeshawk 3 시간 전
AIRI>>>NEWS. Not a penny play but worth a look. HAWK

https://finance.yahoo.com/news/air-industries-group-closes-fiscal-120000021.html
AIRI
MartinLutherKing MartinLutherKing 3 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
vein vein 3 시간 전
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
CKPT

최근 히스토리

USOTC
NPACF
Quadient (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지